ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. (Q38413705)
Jump to navigation
Jump to search
scientific article published on 07 April 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients. |
scientific article published on 07 April 2015 |
Statements
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients (English)
I Ray-Coquard
G Garin
C Cropet
E Verronèse
T Bachelot
P Rebattu
P E Heudel
P Cassier
S Chabaud
T Croughs
P Dupont
A C Cadore
G Clapisson
A Delgado
C Bardin-dit-Courageot
C Rigal
A N'Kodia
L Gilles-Afchain
M Morre
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference